Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.01% | 176.96 | 0.7% | $1383.16m | |
| MRK | Merck & Co., Inc. | 0.66% | 92.50 | 0.7% | $1203.71m | |
| PFE | Pfizer Inc. | 0.55% | 50.94 | 0.9% | $1160.82m | |
| LLY | Eli Lilly & Co. | 1.74% | 323.14 | 1.1% | $1096.78m | |
| BMY | Bristol-Myers Squibb Co. | -0.53% | 78.28 | 1.0% | $1078.11m | |
| ABBV | AbbVie, Inc. | 0.96% | 153.95 | 1.9% | $992.07m | |
| AZN | AstraZeneca Plc | 1.65% | 67.02 | 1.0% | $451.24m | |
| SGEN | Seagen Inc. | 0.33% | 179.06 | 5.7% | $322.85m | |
| TPTX | Turning Point Therapeutics, Inc. | 0.32% | 75.30 | 0.0% | $286.13m | |
| GSK | GSK Plc | 0.97% | 43.77 | 0.2% | $281.98m | |
| HZNP | Horizon Therapeutics Plc | 0.99% | 82.50 | 5.4% | $176.10m | |
| NVS | Novartis AG | 0.70% | 84.76 | 0.2% | $166.17m | |
| MRTX | Mirati Therapeutics, Inc. | -1.84% | 67.24 | 1.6% | $154.95m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.85% | 145.64 | 0.0% | $148.67m | |
| NVO | Novo Nordisk A/S | 1.63% | 110.06 | 0.1% | $146.95m |
Company Profile
Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in San Carlos, CA.